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1. Introduction 
This chapter reviews literature regarding the role of Reg, a family of small C-type lectins, 
with a focus on the endocrine pancreas and introduces novel findings generated in our 
laboratory on the role of Reg as autoantigen in T1DM. It is not intended as a comprehensive 
literature review, but rather discusses a selection of articles in more detail in order to 
illustrate aspects that are important for the understanding of this protein family. In the 
author’s view the scientific challenge consists in the development of a theory of Reg action 
that unifies seemingly disparate roles played by members of this family and provides the 
field of Reg research with a defined framework allowing unification of the many, to date, 
unconnected observations. Thus, although we focus on Reg and the endocrine pancreas, we 
also discuss findings obtained in other Reg research areas that appear to have little 
connection with the endocrine pancreas and T1DM. We choose this approach because we 
consider that the effects of Reg in the endocrine pancreas need to be understood in the 
context of a broader view of this protein family. The reader may easily find a large volume 
of additional literature on the effects of Reg referenced in the presented reports.   
2. Nomenclature and classification of the Reg proteins and the origin of the 
family name  
To act as a guide though the confusing nomenclature of this protein family we have 
prepared a phenogramm of the family incorporating Reg proteins from 5 different species 
(Fig. 1). In the text - as in the phenogramm- we use ‘Reg’, followed by a roman numeral 
designating the subfamily and a Greek letter that designates the member within the 
subfamily. Alternative names are used for those members where no Reg nomenclature 
exists and are otherwise indicated in brackets behind the standard name. ‘Reg’ is used 
without further classification when referring to the entire family. Reg stands for 
‘regenerating islet-derived’, a name, which is not ideal since many Reg proteins are not or 
not solely associated with islet regeneration but function in different tissues and under quite 
diverse physiological conditions, as will be discussed in more detail later. In fact the first 
members of this family were described as a component of pancreatic stones in chronic 
pancreatitis or as constituent of normal pancreatic juice involved in the control of calcium 
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carbonate crystal growth (Keim, Rohr et al. 1984; Multigner, De Caro et al. 1983; Sarles, 
Dagorn et al. 1990). Hence the names PAP or PSP (pancreatitis associated protein or 
pancreatic stone protein) or lithostathine remain in use for some of these proteins. 
Additional designations include ‘pancreatic thread protein’ (PTP), a name given to a bovine 
 
 
Fig. 1. Phenogramm of human (h), mouse (m), rat(r), hamster (ham), and bovine (b) Reg 
family members. ‘Reg’ followed by roman numerals and Greek letters was chosen as 
standard protein name whenever this nomenclature was found in the protein data bank. 
Otherwise the alternative names were used. These are indicated in brackets for members, 
which are found under both the standard and the alternative name in the data banks. 
Protein data bank accession numbers are given after each member. Abbreviations: 
Reg=regenerating islet-derived; INGAP=islet neogenesis associated protein; PTP=pancreatic 
thread protein; PAP=pancreatitis associated protein; HIP=hepatocellular 
carcinoma/intestine/pancreas; PSP=pancreatic stone protein 
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Fig. 2 Alignment of human, mouse, rat and hamster Reg family members. Features of Reg 
discussed in this review are highlighted. Blue background (mRegI): signal peptide; dark 
green background: prosegment (bactericidal effect/fibril formation. The arginine residue at 
the end of the prosegment is part of tryptic cleavage site); light blue background (mRegII): 
N-terminal fragment (acceleration of T1DM, activation of autoaggressive T-cells in NOD 
mice); lime green background: C-terminal fragment (delay of T1DM, T regulatory cells in 
NOD mice); light green letters: EPN motif (carbohydrate binding); gray background: loop 1 
and loop 2 (carbohydrate binding); dark green letters: INGAP peptide (islet 
neogenesis/regeneration); blue letters denote the 6 cysteine residues that form the Reg C-
type lectin domain.  
pancreatic protein that precipitates at neutral pH in the form of double helical threads and 
was subsequently identified as a member of the Reg family (Gross, Brauer et al. 1985) and 
‘HIP’ (for hepatocellular carcinoma, intestine, pancreas) – a name assigned to a human 
family member after Lasserre at al. found that it was overexpressed in a proportion of the 
hepatocellular carcinoma samples they had investigated (Lasserre, Christa et al. 1992). The 
designation ‘Reg’ was introduced because rat RegI (lithostathine) was rediscovered in a 
cDNA library constructed from regenerating islets that had been isolated from the remaining 
pancreases of partially depancreatized, nicotinamide-treated rats (and was not expressed in 
normal islets) (Kobayashi, Akiyama et al. 2000). The investigators had previously shown 
that partial surgical removal of the pancreas followed by nicotinamide treatment induced a 
marked enlargement of the islets of Langerhans due to an increase in the number of -cells. 
They write in their abstract: “The increase in expression of the gene was temporally 
correlated with the increase in size of regenerating islets…” and conclude “Thus the 
expression of the gene in regenerating and hyperplastic islets suggests a possible role for 
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this gene in replication, growth and maturation of -cells”. Looking back on the years of Reg 
research, especially that performed with a focus on islet regeneration the authors of this 
manuscript might, in hindsight, have taken the trouble to remind their readers of an 
important scientific rule, namely, that correlation does not necessarily imply causation.  
Although ‘Reg’ may not be an ideal designation the family is structurally well defined and a 
given protein sequence can unequivocally be assigned to it. To qualify as a member of the 
family a protein has to fulfill only one structural requirement; it must consist of a single C-
type lectin domain of the type found in the first discovered Reg member, without additional 
attached domains. Any newly discovered protein was assigned to the family if it fulfilled 
this requirement and was assigned to a subfamily by primary sequence comparison with 
already existing Reg family members. This classification method resulted in the depicted 
phenogramm in which the three major subfamilies RegI and II, RegIII and RegIV each arise 
from a separate root. To illustrate the features of individual Reg members discussed in this 
review a primary sequence alignment is also shown (Fig. 2).  
3. Studies investigating the role of reg in islet regeneration 
Most studies that have investigated the role of Reg proteins have restricted themselves to 
one particular Reg member. Their basic approach in vivo and in vitro has been to either 
increase or decrease the concentration of the member under study or to add or eliminate it. 
Results of studies that increased Reg concentrations in vivo by administration of exogenous 
Reg protein include the finding that rRegI treatment can ameliorate surgically induced 
diabetes in rats (Watanabe, Yonemura et al. 1994). The same study also found that in vitro 
incubation with rRegI increased incorporation of radioactive thymidine into isolated rat 
islets. A corresponding approach was tested in NOD mice by i.p, administration of hRegI 
with or without co-administration of linomide (Gross, Weiss et al. 1998). This study showed 
that Reg treatment of NOD mice that were still glucose tolerant could significantly reduce 
the incidence of diabetes and, when combined with linomide treatment, led to a reversal of 
glucosuria in glucose intolerant mice. In this study area the hamster INGAP protein 
deserves special mention. It was isolated from hamster pancreas using the cellophane 
wrapping procedure, which induces formation of new islets from pancreatic ducts 
(Rafaeloff, Pittenger et al. 1997). The results reported in this study draw attention to the 
actual definition of the process termed ‘islet regeneration’. Should this term define -cell 
proliferation taking place in pre-existing islets or should it rather describe a process that 
generates ‘new’ islets or -cells from precursor cells? Although -cell replication must 
presumably also take place at some stage in ‘new’ islets generated from precursor cells the 
investigators who discovered INGAP place their emphasis on neogenesis and argue that 
INGAP is associated with this process. Their designation for this Reg member, islet 
neogenesis associated protein, reflects this standpoint as does their demonstration that 
isolated primary duct cells thought to contain potential islet/-cell progenitors respond 
with increased cell proliferation upon incubation with INGAP. The whole area of ‘islet 
regeneration’ is a subject of controversy. There are investigations that establish -cell 
proliferation in preexisting islets as the predominant path to islet regeneration in rodents 
(Dor, Brown et al. 2004) whereas in other studies this process is attributed to the de novo 
formation of -cells from endogenous progenitors (Xu, D'Hoker et al. 2008). ‘Islet 
regeneration’ should perhaps best be understood as the outcome of a combination of several 
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processes including islet neogenesis, -cell proliferation/size increase/maturation and islet 
destruction. As the cited studies show Reg seems to be at least involved in the first two 
processes and might also influence the third via its ability to protect from -cell apoptosis 
(Bonner, Bacon et al. 2010; Simon, Pauloin et al. 2003). 
INGAP is noteworthy from another aspect. The discoverers of this Reg member report in 
their initial publication that they were able to achieve duct cell proliferation not only by 
exposure to full length INGAP but also with a pentadecapeptide corresponding to amino 
acids 104–118 (Fig.2). The investigators seem to have derived this peptide without any 
hypothesis based on a possible effector mechanism of INGAP/Reg or any kind of peptide 
screening approach. We learn that ”We included this region of the deduced protein because 
it differs from another related family of genes known to affect islet regeneration, Reg/PSP, 
in that it has a unique insertion of five amino acids and it precedes a potential N-
glycosylation site situated at position 126, hence, a core of potential biological activity”. 
Although the discovery of this peptide might have been taken as a peculiarity in the Reg 
field it has resulted in a string of subsequent investigations all showing some positive effect 
of a peptide with this sequence and corresponding peptides from other Reg members on 
diabetes and/or ductal cell proliferation. The findings finally led to a trial in humans, which 
again demonstrated positive effects in type 1 as well as in type 2 diabetic patients (Dungan, 
Buse et al. 2009; Levetan, Upham et al. 2008; Pittenger, Taylor-Fishwick et al. 2007; 
Rosenberg, Lipsett et al. 2004).  
We have detailed the INGAP studies because they illustrate some important problems 
affecting the Reg field especially concerning diabetes/islet regeneration. No unequivocal 
effector mechanisms have been defined for this family and therefore it is not known if and 
how the differences between family members might manifest themselves clinically. It is not 
clear what process of ‘islet regeneration’ is preferentially impacted by Reg. Do all Reg 
members act as -cell mitogens? Can all Reg members induce islet neogenesis and are all 
Reg members equally able to protect -cells from apoptosis? Since these questions have not 
been answered we are left with a collection of observations lacking a basis (or a precise 
theory) from which they can be explained. As a consequence, it is difficult to generate 
testable hypotheses that would, for example, predict which cells should proliferate upon 
Reg stimulation and which should not, or that would allow improvement of the INGAP 
peptide sequence to produce a peptide with better mitogenic/anti inflammatory/anti-
apoptotic/islet neogenesis-inducing properties. 
Studies using overexpression or knockout mouse models to demonstrate Reg effects will be 
briefly considered here. As mentioned above there is no theory available that would predict 
which of the Reg members would be most promising for these studies and investigators 
have therefore tried different Reg candidates in these test systems. The first member to be 
tested in knockout experiments was RegI and this was also the first to be overexpressed in 
pancreatic islets under an insulin promoter (Unno, Nata et al. 2002). Overall, the results 
from these studies supported the observations obtained on exogenous administration of 
Reg. RegI ko mice had morphologically normal pancreatic islets and were euglycemic. 
However islets isolated from these mice incorporated less radioactive thymidine than islets 
from non-transgenic mice. Furthermore, stimulation with aurothioglucose, a method of 
inducing hyperplastic islets, failed to increase islet size in RegI ko mice to the same extent as 
it did in non transgenic mice, again supporting a mitogenic effect. A group that reported 
results on a knockout of RegIII found that the mice were more sensitive to caerulein-
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induced pancreatitis but the report did not mention any deleterious effect of this genotype 
on islet size, insulin or glucose levels, suggesting that there may have been no difference 
between knockout mice and normal littermates (Gironella, Folch-Puy et al. 2007). Expression 
of transgenic mRegI under the insulin promoter in -cells did not affect the size or 
morphology of islets compared to non-transgenic mice. However, when mRegI transgenic 
mice were crossed onto NOD mice the incidence of T1DM in the NOD RegI transgenic mice 
was significantly reduced compared to normal NOD mice (Unno, Nata et al. 2002). 
Subsequent mouse models tested the effects of transgenic expression of hamINGAP and 
mRegIII targeted to islets via an insulin promoter (Chang, Weaver et al. 2010; Xiong, Wang 
et al. 2011). These studies found enhanced glucose tolerance, partial protection from 
streptozotocin (STZ)-induced diabetes and alterations in gene expression profiles when 
compared to non-transgenic mice. Overexpression of mRegII targeted to the exocrine 
pancreas with an elastase-1 promoter failed to provide protection from streptozotocin-
induced diabetes (Li, Wang et al. 2010), whereas hamINGAP targeted to the exocrine 
pancreas with the same promoter did confer resistance to STZ-induced diabetes and 
increased the -cell mass (expressed as insulin positive cells and the total pancreatic 
insulin/protein ratio) as well as the number of smaller islets compared to non transgenic 
littermates (Taylor-Fishwick, Bowman et al. 2006). The findings obtained from the two 
transgenic models with exocrine targeting of mRegII or hamINGAP were interpreted to 
indicate that different Reg members could have different effects. None of the more recent 
transgenic Reg models has so far been crossed onto the NOD background to study the 
impact of Reg overexpression in a T1DM model. The general conclusion from these studies 
is that Reg-induced effects appear to be pleiotropic probably impacting at least the three 
known processes mentioned above that contribute to ‘islet regeneration’.  
In our discussion of the effects induced by Reg, as derived from the presented findings, we 
place emphasis on a feature that was not observed in mice treated with exogenous Reg or in 
Reg transgenic mice. It is noteworthy that in the studies presented above euglycemia was 
maintained in the treated mice, hypoglycemia or excessive serum insulin levels were not 
observed and increases in islet mass were limited. This implies that the effects of exogenous 
(or transgenic) Reg as -cell mitogen or stimulator of islet neogenesis did not lead to an 
expansion of the islet mass beyond what is physiologically normal. This feature is especially 
apparent in the transgenic models, where Reg is expressed from a constitutive promoter 
leading to sustained Reg overexpression from an early time-point. In this situation it is 
tempting to argue that the absence of documented effects in these studies suggests that the Reg 
proteins do not have any effects under normal physiological conditions. However, a different 
argument can be presented. The findings might indicate that the effects of Reg on ‘islet 
regeneration’ are tightly regulated and do not exceed the limits imposed by the target system, 
be it -cells/islets or ductal precursor cells. In other words, when normal and transgenic mice 
are compared under normal, non-experimental conditions clinical differences are not found 
because the effect of the additional experimentally provided Reg input remains marginal. If 
this situation were expressed in the form of a hypothetical Reg effect curve where the X-axis 
represents the concentration and the Y-axis the effect, addition of exogenous or transgenic Reg 
would occur close to or at the point where the curve levels off i.e. adding more Reg at this 
stage would only have a marginal effect. In this model the system is kept close to the point of 
saturation due to the presence of endogenous Reg members and additionally due to the 
overlapping effect range of the various Reg members where one member can compensate at 
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least to some extent for the loss of others. Thus knockout or overexpression of one Reg 
member shows little effect under normal conditions because the reduction/increase in the 
overall Reg concentration is small compared to the basal concentration that is provided by 
endogenous Reg members and keeps the system close to saturation. According to this 
interpretation it is possible that the effects of Reg are extremely important in the generation 
and maintenance of islet mass under normal conditions with an entire family of closely-related 
Reg members with overlapping functions rather than a single protein being necessary as a fail-
safe mechanism to protect this function in a system that has to be kept at or close to saturation. 
Consequently this view would predict that, in order to better reveal the effects of Reg, a 
pronounced reduction in the Reg concentration by knocking out more than one and possibly 
all Reg members would be necessary.  
 
 
Fig. 3. Reg expression in human and murine islets. RegI, RegI and RegIII (HIP/PAP) are 
expressed in human endocrine pancreas whereas RegII and RegIII are expressed in murine 
islets. (scale bar =50µm) 
Such a multimember knockout model would be within the current technical capabilities 
because in the mouse all Reg family members except RegIV are located on one contiguous 
75kb stretch of DNA (Kobayashi, Akiyama et al. 2000), and could therefore be knocked out 
as a whole. In such a model the effects of exogenous administration of Reg even under 
normal conditions might be quite spectacular or absolutely necessary for the survival of the 
animals with this genotype. Although this prediction might be considered a little extreme 
there are a few observations, which might support it. As we and others have shown, 
individual Reg family members seldom appear on their own. Wherever one family member 
is expressed others are likely to be found as well (see Fig. 3). Most importantly, the 
individual Reg members all contain the Reg C-type lectin domain, which is a strong 
indication that some of their functions may overlap and therefore generate redundancy. In 
terms of the hypothetical Reg effects graph mentioned above this means that the X-axis Reg 
concentration is unlikely to be derived from one single Reg member but is rather a result of 
the cumulative concentrations of all Reg members present at this site.  
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4. Studies in search of a reg receptor 
The potentially pleiotropic effects of Reg emphasize the importance of defining if, where, 
when, and how the Reg members bind. A receptor for Reg, which are secreted proteins, 
might act as focal point for Reg action and might enable us to place the events taking place 
upon receptor binding and the subtype specific characteristics of the Reg family within a 
theoretical framework. There has only been one investigation that specifically set out to 
isolate an islet Reg receptor (Kobayashi, Akiyama et al. 2000). In this study an expression 
library of rat pancreatic islets was probed with rRegI. This led to the isolation of a cDNA 
that had significant sequence homology to those  “of multiple exostoses (EXT) family genes 
especially to human EXT-like gene 3 (EXTL3)/ EXT-related gene 1 (EXTR1) (over 97% amino 
acid identity), indicating that the cDNA encodes a rat homolog to human EXTL3/EXTR1”. 
EXTL genes are homologs of the EXT genes, which have been linked to hereditary multiple 
exostoses (HME), a rare medical condition in which multiple bony spurs or lumps (also 
know as exostoses or osteochondromas) develop on the bones of a child. However, EXTL 
genes are not linked to HME. EXT1 and 2 are thought to form Golgi-located hetero-
oligomeric complexes and EXTL 1 and 3 contain a putative transmembrane domain with a 
short (31 amino acid for EXTL3 cytoplasmic domain) (Busse, Feta et al. 2007). All EXT family 
members are glycosyltransferases, which are involved in the biosynthesis of heparan sulfate 
and its analog heparin. EXT1 and 2 are essential for chain polymerization of heparan sulfate 
whereas EXTL3 most likely is involved in both chain initiation as well as elongation of 
heparan sulfate (Kim, Kitagawa et al. 2001). Heparan sulfate is a glycosaminoglycan found 
abundantly on the surface of most cells and in the extracellular space as proteoglycan. 
Heparan sulfate (HS) proteoglycans are involved in a wide range of biological processes 
such as cell adhesion, morphogenesis, cytokine effects and regulation of growth factors 
(Bernfield, Gotte et al. 1999). Regulation of HS proteoglycan biosynthesis would therefore be 
a good starting point to explain the pleiotropism of the Reg effects. However, the effects of 
Reg binding to EXTL3 are not known. Does this disrupt or enhance HS proteoglycan 
biosynthesis? How and where on the EXTL3 molecule does Reg bind and do different Reg 
members have different affinities? We do know that PANC-1 cells when incubated with a 
human version of the INGAP pentadecapeptide mentioned above respond with an 
accelerated translocation of the EXTL3 protein to the nuclear subcellular fraction (Levetan, 
Upham et al. 2008). Unfortunately, in this study, no alanine scans (mutated peptides each of 
which has an alanine replacing the naturally occurring residue at a different position in the 
sequence) or truncation or comparison studies with corresponding pentadecapeptides from 
other Reg members were performed. It is also known that islets contain HS (proteoglycans) 
and that heparinase treatment of isolated islets reduces their glucose responsiveness 
(glucose stimulated insulin secretion, GSIS). Furthermore islets of mice with a -cell specific 
ablation of EXTL3 obtained with a rat insulin 2 promoter-Cre/loxP-system had reduced 
GSIS, a reduced number of insulin positive cells and, until the age of four weeks, fewer cells 
positive for the proliferating cell nuclear antigen.  These mice also responded to glucose 
challenge with increased blood glucose levels and their plasma insulin levels were reduced. 
These findings demonstrate that -cell specific EXTL3 knockout can affect the regulation of 
postnatal islet maturation via ablation or reduction or alteration of HS proteoglycan 
biosynthesis (Takahashi, Noguchi et al. 2009).  
These encouraging data might lead to the formation of a basis from which the effects of Reg 
could be explained. However, large gaps in our knowledge remain. It is not clear if Reg 
binding to EXTL3 changes HS proteoglycan synthesis and if so how. Even if Reg binding to 
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EXTL3 were to cause an alteration in HS proteoglycan synthesis it is not clear if this would 
be sufficient to explain the effects seen in the models with transgenic expression or 
exogenous administration of Reg. There is therefore room for consideration of other 
potential Reg receptors. The methodology used in the experiments that discovered EXTL3 as 
Reg receptor involved screening of an islet cDNA library expressed in bacteria with rRegI. 
However proteins in a bacterial expression system are not subject to the same glycosylation 
that is introduced in a eukaryotic cell. Due to these limitations the screening assay could not 
detect Reg binding to carbohydrate structures found on glycoproteins or proteoglycans in 
eukaryotic cells. Reg-carbohydrate interaction however is an area that should definitely be 
covered by a search for potential Reg receptors because the family-defining structural 
feature of the Reg proteins is the C-type lectin domain. Lectins are proteins that bind to 
carbohydrate structures and C-type lectins do this better in the presence of calcium ions or 
their binding to carbohydrates is dependent on the presence of these cations. Surprisingly, 
despite the presence of a canonical C-type lectin fold, Reg-carbohydrate binding in the 
context of islet regeneration has so far not received any attention at all. A reason for this 
may possibly be that Reg proteins lack conserved amino acid residues that support Ca2+-
dependent carbohydrate binding in other C-type lectins (Drickamer 1999). However this in 
no way rules out the possibility that Reg proteins recognize carbohydrate epitopes. To 
uncover what is known about this property of Reg it is necessary to leave the area of islet 
regeneration and explore other fields of Reg research.  
5. Reg effects in areas other than islet regeneration 
5.1 Reg as a carbohydrate-binding bactericidal lectin and fibril-forming protein in 
degenerative processes afflicting the brain 
Researchers studying the Reg family of proteins often work with a test system that involves 
the application of an artificial noxious stimulus thought to mimic a naturally occurring 
stress event. In a screen performed after application of the stimulus overexpression of one or 
more Reg members is observed. This was the case with the study that described the 
discovery of rRegI in regenerating pancreas and of INGAP. Recently a group of scientists 
investigating how gut microbial flora is maintained and controlled performed a study that 
compared gut epithelial cells from germ-free mice with those of mice that had been 
reconstituted with an intestinal microflora from conventional mice. They write ”…To gain 
new insights into how intestinal surfaces cope with microbial challenges, we used DNA 
microarrays to identify Paneth cell antimicrobial factors whose expression is altered by 
bacteria. [….] The results of our screen revealed 149 transcripts whose expression was 
changed 2- to 45-fold by microbial colonization. One of the most prominent responses 
uncovered by our analysis was a 31-fold increase in the abundance of RegIII transcripts in 
Paneth cells from conventionalized as compared with germ-free mice”. Subsequently this 
group demonstrated that mRegIII and hRegIII were bactericidal for Gram-positive 
bacteria. The bactericidal effect could be fully blocked by addition of chitotetraose 
(GlcNAc4) and somewhat attenuated by the addition of soluble peptidoglycan fragments, 
chitobiose (GlcNAc2), or N-acetylglucosamine. Interestingly, this assay revealed clear 
differences in susceptibility to glycan blocking between the mRegIII and hRegIII. 
Precipitation experiments and binding studies revealed that both mRegIII and hRegIII 
had affinity for peptidoglycans as well as mannan and chitin (Cash, Whitham et al. 2006).  In 
a subsequent publication this group demonstrated that a short N-terminal peptide 
controlled the antibacterial activity of mRegIII and hRegIII. This peptide spans the region 
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between the end of the leader sequence and a canonical trypsin cleavage site that is 
conserved in all but the RegIV subfamily where the conserved arginine residue is followed 
by a proline thus blocking tryptic cleavage (see Fig. 2). The group found that removal of the 
prosegment by tryptic cleavage drastically increased the antibacterial properties of the two 
Reg members. They also showed that removal of the prosegment did not interfere with 
peptidoglycan binding, which is essential for the antibacterial effects and suggest that the 
prosegment exerts its blocking activity via a mechanism different from interference with 
Reg-peptidoglycan binding. The authors propose that this regulatory mechanism has 
evolved to give the host control over antibacterial activity and that the activation of Reg by 
cleavage of the small inhibitor peptide likely occurs in the lumen of the gut by two trypsin 
isozymes, which are expressed in gut epithelial cells (Mukherjee, Partch et al. 2009). It 
should be added that, as mentioned before, some Reg members are secreted by the exocrine 
pancreas under normal physiological conditions and this might therefore be another site of 
activation of Reg for release of antibacterial effects. A third publication of this group reports 
on the molecular basis for peptidoglycan recognition by mRegIII and hRegIII. In this 
study the researchers used solution nuclear magnetic resonance to identify residues of 
hRegII involved in peptidoglycan binding. The three-dimensional structure of Reg is the 
C-type lectin fold containing a characteristic ‘long loop’ structure. In this long loop two 
subdomains can be distinguished which the scientists have designated loop 1 and loop 2. In 
other C-type lectins the loop 2 is involved in Ca2+-dependent carbohydrate binding via 
specific amino acid residues (the EPN motif, Fig. 2). However the corresponding residues in 
hRegIII (HIP/PAP) are not found in loop 2 but in loop 1 and, as the authors of the study 
show, participate in carbohydrate binding. Also missing in hRegIII are two conserved 
residues in the 4 strand of the C-type lectin fold, which are necessary for carbohydrate 
binding in other C-type lectins. Thus although these Reg family members lack the canonical 
C-type lectin carbohydrate binding motifs they are nevertheless lectins. Interestingly, based 
on the presence of the EPN motif in loop 1 scientists were able to predict that mRegIII 
should bind peptidoglycans whereas mRegIII, which lacks this motif should not. They 
were then able to confirm this prediction experimentally (Lehotzky, Partch et al. 2010). What 
conclusions can be derived from this?  First, it should be appreciated that a C-type lectin 
domain can apparently bind carbohydrates via more than one mechanism. The domain 
functions as a three-dimensional scaffold within which changes affecting fine specificity are 
possible, allowing generation of diversity in carbohydrate binding. It is therefore quite 
conceivable that other Reg members also possess these properties despite lacking many or 
all of the residues that constitute the canonical C-type lectin carbohydrate binding motifs. 
These findings additionally give rise to new questions. All Reg members (except RegIV) 
contain the trypsin cleavage site, necessary for removal of the blocking peptide from 
hRegIII and mRegIII. Would this mean that all Reg members are potentially bactericides 
or only those containing the EPN motif in loop 1? This would make RegIII a bactericidal 
protein, while, as mentioned above, also protecting islets from STZ-induced diabetes when 
overexpressed (Xiong, Wang et al. 2011). What is the actual bactericidal mechanism of such 
Reg proteins? In studies on mRegIII Mukherjee, et al. discovered that carbohydrate binding 
per se is insufficient to explain this effect. Removal by tryptic cleavage of the short N-
terminal blocking peptide does not interfere with carbohydrate binding yet drastically 
increases the bactericidal effect of the two investigated RegIII members (hRegIII and 
mRegIII). Is there a Reg effect that can manifest itself as bactericidal in the gut but as 
protective in pancreatic -cells? Or can Reg proteins act in different ways depending on 
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whether they are ‘trypsin-activated’ or not? It should also be noted that RegIV, which has a 
blocked tryptic cleavage site and can therefore not undergo the unblocking process leading 
to an active bactericidal Reg member and has a deleted EPN motif nevertheless does bind 
carbohydrates (Ho, Lou et al. 2010). Perhaps the carbohydrate-binding step is common to all 
Reg members, with effector mechanisms diverging downstream of this event.  
In this context it is noteworthy that trypsin cleavage of Reg, which was discovered some 
years ago was reported to convert the previously soluble protein into a form that 
precipitates above pH6.5 and forms oligomeric fibrillar structures that combine into 
quadruple-helical filaments (QHF). It was also suggested that the small Reg prosegment 
inhibits formation of these fibrils. It was furthermore observed that rRegI is actually cleaved 
at the conserved trypsin site under conditions that rule out the presence of trypsin and other 
proteases thus suggesting that Reg may be subject to self-proteolysis at this site (Cerini, 
Peyrot et al. 1999) (Schiesser, Bimmler et al. 2001). Reg fibril formation may have profound 
consequences in degenerative processes in the central nervous system. These fibrils were 
found to be present in the pathological lesions of Alzheimer’s disease and hRegI was 
found to be overexpressed during very early stages of the disease before clinical signs 
appear (Duplan, Michel et al. 2001). Furthermore hRegI (lithostathine-1) deposits were also 
observed in the blood vessels and in focal and multicentric plaques in the cerebellum of 
patients with Creutzfeldt-Jacob disease (Laurine, Gregoire et al. 2003). The authors of these 
studies suggest that Reg fibrils might represent a common component of amyloid deposits 
and may be a component of the material that coats amyloid fibrils observed clinically. This 
raises the question as to whether Reg could play a role as a link between brain injury and 
the later onset of neurodegenerative diseases. If indeed this protein possesses the ability to 
undergo a process of self-proteolysis promoting the tendency to fibril formation then 
overexpression of Reg members in response to traumatic brain injury, which is well-
documented as discussed below, might under certain circumstances contribute or even act 
as trigger for subsequent degenerative processes.   
To return to the bactericidal properties of Reg: fibril formation might actually be a process 
that contributes to its antibacterial effect. In such a scenario binding of Reg to bacterial 
carbohydrates would provide an anchorage and would be followed (or accompanied) by 
tryptic activation, which then leads to the formation of a Reg fibrillar coat on the surface of 
the bacteria. This coat could either inhibit bacterial movement or ‘plug’ channels in the 
bacterial cell wall or possibly cause perforation of the cell wall. A way to investigate this 
hypothesis would be to test if drugs that can dissociate Reg fibrils into individual 
protofilaments can actually reverse the bactericidal effect of Reg. Two remarks should end 
this section. The loop 1 of the C-type lectin domain that contains the EPN motif in mRegIII 
and hRegIII, described above, overlaps to a large extent with the peptide of INGAP 
reported to stimulate islet neogenesis (although there is no EPN motif in INGAP, see Fig. 2). 
Thus the intuition of the discoverer of this peptide was correct in so far as the loop 1 indeed 
corresponds to “a core of potential biological activity”. Although it should be added that a 
loop that has been cut at both ends no longer corresponds to a loop. These findings, together 
with the discovery by Christa et al. in 1994 that hRegIII (HIP/PAP) acted as a C-type lectin 
that bound to the disaccharide lactose (Christa, Felin et al. 1994) indicate that Reg proteins 
can bind carbohydrates despite the absence of the canonical binding motifs found to be 
essential for this task in other C-type lectins. This underlines the consideration that the rules 
governing carbohydrate binding in Reg C-type lectins are more complex than we currently 
understand.  
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5.2 Reg as regenerative factor in the nervous system and modulator of inflammatory 
responses 
Involvement of the Reg family of proteins in nerve cell regeneration was observed while 
screening for genes overexpressed in an rat model that investigates motor neuron 
regeneration after crushing of the sciatic nerve. The authors write: “Within 24h of crushing 
the sciatic nerve, all motor neurons and a subpopulation of sensory neurons express high 
levels of rReg-2 (rRegIII/PAP-1) mRNA and protein. This again exemplifies the standard 
process of discovery for this family. The authors observed that migration of rReg-2 along 
growing motor and sensory axons occurs via orthograde transport and that rReg-2 acts as 
mitogen to Schwann cells, the cells that create the support on which neuronal regrowth can 
take place. Intraneural injection of an antiserum, which blocks rReg-2 greatly reduced 
regeneration of neurons. Interestingly, the authors found that recombinant rReg-2 alone had 
only a weak mitogenic effect on Schwann cells. However this effect could be enhanced by 
addition of forskolin, an activator of adenylate cyclase. It should be noted that the discovery 
of rRegI in a model of islet regeneration mentioned before involved the treatment of rats 
with nicotinamide, an inhibitor of 3’-5’ cAMP phosphodiesterase. Thus forskolin and 
nicotinamide both increase the intracellular levels of cAMP leading to an amplification of 
Reg-induced mitogenic effects. The authors mention that enhancement of the mitogenic 
effect by forskolin is also seen with other Schwann cell mitogens such as glial growth factors 
and platelet derived growth factor. There it is attributed to cAMP-induced increase in 
receptor expression for those factors. In an attempt to trace the signal that induced 
overexpression of rReg-2 the authors investigated the effects of peripheral axotomy on Reg-
2 expression in the neonatal period when motor neurons are particularly sensitive to this 
intervention. The sensitivity to axotomy is ascribed to the interruption of retrograde 
transport of peripherally-derived neurotrophic factors. Indeed they found that the 
intervention greatly reduced constitutive Reg-2 expression levels compared with uninjured 
motor neurons. This finding indicated that Reg-2 expression in developing motor neurons 
was dependent on contact with peripheral targets, which act as source of neurotrophic 
factors. The authors argued that these factors might be leukemia inhibitory factor or ciliary 
neurotrophic factor (LIF/CNTF) because these proteins are related to the IL-6 family of 
cytokines and rReg-2 and other Reg gene family members have IL-6 responsive elements 
in their promoter region. They could show that targeted disruption of gp130, which is a 
common component of the receptors for IL-6, LIF, CNTF and CT-1 indeed abolished Reg 
expression in developing motor and sensory neurons of the mutant mice thus 
demonstrating that the expression of the mouse Reg protein(s) at this site is dependent on 
the cytokines of the LIF family acting through the LIF receptor (Livesey, O’Brian et al. 
1997).  
This study was expanded subsequently by another group of scientists who showed that 
CNTF-related cytokines could induce rReg-2 expression in cultured motor neurons, which 
in turn acts as an autocrine/paracrine neurotrophic factor for a subpopulation of motor 
neurons by stimulating a survival pathway involving phophatidylinositol-3-kinase, Akt 
kinase and NF-B. They also demonstrated that rReg-2 expression in vivo is controlled on a 
cell-by-cell basis and that not all neurons that have the LIF receptor express Reg-2. Since, by 
the time this report was prepared, the EXTL3 islet Reg receptor had already been identified 
the authors also performed rtPCR on motor neurons cultured with CNTF but failed to find 
mRNA for EXTL3. This resulted in the conclusion that “the Reg-2 receptor in motor neurons 
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probably remains to be identified” (Nishimune, Vasseur et al. 2000). Over a decade later this 
receptor has still not been identified. In our opinion this is related to the little-appreciated 
fact that Reg proteins are lectins and therefore bind carbohydrates. Both studies presented 
again show pleiotropic effects of Reg impacting on the one hand Schwann cell mitogenesis 
and on the other hand motor neuron survival.  
Before leaving this area two additional studies on the effects of Reg in the nervous system 
should be mentioned. The first provides an example of the observation that Reg family 
members are seldom found alone while the second introduces yet another role for mRegIII, 
which has been identified as a potential bactericidal lectin, an islet regeneration factor and 
an inflammatory modulator in pancreatitis. The first study used a model that induces 
traumatic brain injury (TBI) by weight drop and then studied the expression of rat Reg 
members by quantitative real-time PCR and in situ hybridization in the cerebral cortex. This 
study reported a low level of rReg-2 (rRegIII/PAP-1) and of rRegIII (PAP-III) mRNA in 
normal animals. Upon surgery and TBI the mRNA levels of both rat Reg members increased 
dramatically. First rReg-2 mRNA increased 12hrs post TBI and remained elevated until day 
5 post TBI. This was followed, at 24 hrs post TBI, by rRegIII mRNA with a sharper 
temporal peak persisting until day 3 post TBI. The mRNA level of rReg-2 was also 
somewhat elevated in the cortex contralateral to TBI and the sham-operated ipsilateral side 
(Ampo, Suzuki et al. 2009). Two points here are relevant. First, low levels of Reg mRNA are 
detected in normal cortex, and as mentioned above, more than one Reg member is 
expressed. As shown in Fig. 3 this also correlates to the situation in pancreatic islets and 
would suggest redundancy due to overlap in the effector mechanisms mediated by different 
Reg members and a role for these proteins not only in response to stress but also under 
normal physiological conditions.   
The second study described the generation of a mouse model in which the exons 2-5 of the 
gene encoding mRegIII had been deleted and replaced with a lacZ reporter selection 
cassette. These mice were phenotypically indistinguishable from wild-type or heterozygous 
littermates. Interestingly, the knockout mice exhibited marked elevation of expression of 
mRegIII suggesting that the Reg system is designed to contain redundancies where one 
Reg member to some extent compensates for loss of another. The authors of this study 
provide evidence that, as in the case of rReg-2, expression of mRegIII is restricted to certain 
neuronal populations and is also developmentally regulated. Peak RegIII expression was 
observed on postnatal day 4 and had disappeared from all areas of the brain and spinal cord 
by postnatal day11. mRegIII deletion did not affect the total number of motor neurons in 
the facial motor nucleus, suggesting that no neuronal cell death had resulted from the loss of 
mRegIII. As in the aforementioned knockout studies, it was the application of a noxious 
stimulus that clearly revealed the effect of the knockout. When the scientists severed the 
facial motor nerve at postnatal day 3.5 and applied either saline or CNTF to the cut end of 
the nerve, more CNTF-treated motor neurons survived in the wild-type mice than in the 
knockout mice where CNTF treatment showed no improvement in survival over saline 
(Tebar, Geranton et al. 2008). In the latter case, as in pancreatic islets, knockout of a single 
Reg member causes no or only mild effects under normal physiological conditions. Only 
when a noxious stimulus is applied do the effects of the knockout become visible. As 
described above we attribute this to the presence of compensatory effects induced by other 
Reg members leading to saturation of the system under normal conditions, hence our 
www.intechopen.com
 Type 1 Diabetes – Pathogenesis, Genetics and Immunotherapy 
 
174 
advocacy of a multimember Reg knockout model and experiments designed to demonstrate 
the redundancies predicted to exist within the Reg family.  
The neuronal role of Reg also extends to effects on macrophages. We previously mentioned 
publications that investigated the role of rReg-2 (rRegIII/rPAP-1) and of mRegIII in the 
neuronal context. As was to be expected more than one Reg member is involved in this 
process. rRegIII is not only overexpressed in the cerebral cortex in response to traumatic 
brain injury as briefly mentioned above but also in the Schwann cells upon nerve injury 
(Namikawa, Fukushima et al. 2005). Injuries to axons in the peripheral nervous system 
induce the degeneration of distal axons, a process, which is accompanied by cellular 
responses. Among these responses the most striking is the invasion of the degenerating 
nerve by macrophages. They clear debris consisting of myelin components that inhibits 
axonal growth and secrete a number of soluble factors that can stimulate axonal growth. The 
influx of macrophages is ascribed to attractants that are released from the Schwann cells, 
which have undergone dedifferentiation as a consequence of loss of axon-Schwann cell 
contact. A number of such attractants have been described and include LIF and the 
monocyte chemoattractant protein-1 (MCP-1). Using a two-chamber cell migration assay 
Namikawa et al. could show that rRegIII is equally effective as MCP-1 in promoting 
macrophage migration. The scientists produced a dose-response curve that showed an 
increase in the macrophage migration index at concentrations of rRegIII between 0.1 and 
10ng/ml. Doses above 10ng/ml did not further increase this index but rather led to a 
decrease with the effect completely disappearing at 500ng/ml, therefore revealing an 
effective concentration range typical for cytokines and chemokines. The authors also 
demonstrated that rRegIII knock-down achieved with siRNA introduced into rat nerves by 
adenoviral gene transfer reduced the capacity of explanted nerve segments distal to the 
injury to attract macrophages (Namikawa, Okamoto et al. 2006). However, attraction is not 
the only effect on macrophages ascribed to Reg. rRegIII (PAP-2) is also able to modulate 
the inflammatory response in these cells. Viterbo et al. showed migration of macrophages to 
beads coated with rRegIII with subsequent agglutination. They also demonstrated that 
this Reg member binds to macrophages, but do not reveal whether this occurs via EXTL3 
the islet Reg receptor, or via a different receptor. (We suggest that it occurs via 
carbohydrate binding). They then measured, by real-time PCR and ELISA, a range of 
cytokine responses in the macrophages during exposure to rRegIII. They reported 
upregulation of mRNAs for IL-1, IL-6, TNF and IL-1 most likely via the NF-B 
pathway (Viterbo, Bluth et al. 2008).  
Considering the roles of Reg introduced here the general conclusion may be drawn that Reg 
proteins are functionally placed well within the large family of endogenous lectins of which 
C-type lectins are a subgroup (Mascanfroni, Cerliani et al. 2011; Toscano, Ilarregui et al. 
2007). These endogenous glycan-binding proteins have been implicated in a wide range of 
functions including first-line defense against pathogens (bactericidal effect of Reg) cell-
trafficking (macrophage attraction of Reg), immune regulation (cytokine responses induced 
by Reg) neoplastic transformation (Reg expression in liver cancer). Reg is unique among the 
C-type lectin family in that it consists of a secreted lectin domain only. This feature makes its 
distribution wider than that of C-type lectins, which constitute part of receptors in the cell 
membrane. It is therefore possible that Reg can also act as a modulator of the interactions 
between lectins in receptors and their carbohydrate ligands (van Vliet, Garcia-Vallejo et al. 
2008).   
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6. Reg as autoantigen in T1DM 
Returning to the endocrine pancreas we now focus on studies performed in our laboratory 
that investigate the possibility that Reg might act as an autoantigen in T1DM. The insight 
that the pathogenesis of T1DM is driven by a disorder of the immune system has been well 
established by numerous animal experiments and clinical observations. That certain MHC 
alleles are associated with an increased risk of developing T1DM, that antibodies are present 
against -cell self antigens and that lymphocyte infiltrates are observed in the endocrine 
pancreas all point to the adaptive immune system, i.e. B- and T-cells, as necessary elements 
in the process leading to islet damage/destruction and thus insulin dependency. Although 
insulin has received much attention in the search for potential cellular targets of the 
autoimmune process it has become evident that it is not the only -cell component to which 
self-reactivity exists in T1DM. Our initial interest in the Reg proteins arose following our 
observation that one of its members, hRegIII, (HIP/PAP) was overexpressed in the 
remaining pancreatic islets of a patient who had died shortly after onset of the disease. This 
raised the question as to whether a vicious circle could become operational in a situation 
where a protein that becomes overexpressed as a result of the inflammatory process in the 
pancreatic islets, subsequently functions as an autoantigen (Gurr, Yavari et al. 2002). We 
therefore investigated if such a situation could occur during the pathogenesis of T1DM using 
the NOD mouse as model. We first defined Reg members present in mouse islets and found 
RegIII as well as RegII and, in more heavily infiltrated islets, also RegIII. RegIII expression 
was restricted to non -cells of the islets while RegII was found throughout the endocrine 
pancreas (Fig. 3). In the NOD model of T1DM autoantigens such as insulin and glutamic acid 
decarboxylase have been used as vaccine antigens to prevent or delay the onset of the disease. 
If a Reg member acted as autoantigen it might also have these properties and we therefore 
tested both RegII and RegIII as vaccines. While we could not prevent or even delay T1DM 
with RegIII we found a clear preventive effect with RegII vaccination. To ascertain that this 
effect was due to an immune-mediated process and not to the potential effects of Reg on islet 
regeneration we cleaved RegII into two fragments. The N-terminal fragment (NtfrII, residues 
22-75) contained the first three cysteine residues of the Reg C-type lectin domain and the C-
terminal fragment (CtfrII) contained the remainder of the protein (see Fig. 2). This, we argued, 
would inactivate possible direct effects of RegII on islet regeneration while retaining the 
function of Reg as autoantigen. On testing the two fragments we found that vaccination with 
the N-terminal fragment actually accelerated disease whereas vaccination with the C-
terminal fragment delayed disease. This delay was more pronounced than that achieved 
with the full-length protein. In addition, it could be induced with late stage vaccinations, 
that is, delaying vaccination until shortly before onset of T1DM in NOD mice. We next 
demonstrated by adoptive transfer experiments that the clinical effects were mediated by T-
cells. Both CD4+ and CD8+ T-cells from donors vaccinated with the N-terminal fragment 
could transfer disease to NOD-SCID mice - a strain that lacks B and T-cells and therefore 
does not develop T1DM. Similar experiments with T-cells obtained from donors vaccinated 
with CtfrII showed that CD4+ T-cells from these mice could delay the onset of T1DM 
induced by diabetogenic T-cells. Taken together these experiments clearly demonstrated 
that the clinical effects seen after RegII vaccination were in fact immune-mediated and not a 
result of a direct effect of RegII on islet regeneration. They also identified the N-terminal 
fragment of RegII as the part of the protein that contained T-cell epitope(s) able to activate 
autoreactive T-cells, whereas it appeared that vaccination with the C-terminal fragment had 
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activated T-regulatory cells. We had thus established that RegII could act as an autoantigen 
in T1DM of NOD mice (Gurr, Shaw et al. 2007). Another group had demonstrated in the 
meantime that 24.9% of patients with T1DM, 14.9% of patients with type 2 diabetes and 2.7 
% of control subjects had autoantibodies against RegI, thus confirming that Reg can also 
become a target of the autoimmune response in humans (Shervani, Takasawa et al. 2004). To 
add the second component of the vicious circle postulated above we had also shown that 
isolated human islets, when incubated with IL-6, secreted increased amounts of hRegIII 
(PAP/HIP). In a pancreatic islet under autoimmune attack this cytokine might be released 
by infiltrating macrophages leading to overexpression of Reg. Reg in turn then, since it acts 
as autoantigen, and as attractant for macrophages, as discussed above, enhances the 
inflammatory process thus leading to further overexpression and the operation of a vicious 
circle. However, we wanted to know if this process actually occurred in vivo. Autoantigens 
drain from the islets to the pancreatic lymph nodes where they are processed by antigen-
presenting cells to generate peptides for display in the context of MHC molecules. Self-
reactive T-cells are activated by these complexes, proliferate and migrate to the islets where 
they exert their deleterious effects. Since NtfrII activated self-reactive T-cells it had to 
contain one or more T-cell epitope(s). If at any time during the pathogenesis of T1DM a 
vicious circle operated then an increase in the NtfrII peptide MHC complexes should occur 
in the pancreatic lymph nodes. This should be followed by an increase in proliferation of T-
cells specific for NtfrII. NOD mice only have one classII MHC molecule, namely I-Ag7. We 
therefore generated an antibody, termed D9 that was able to detect an NtfrII-derived 
peptide in context of I-Ag7. This antibody was phage-displayed, that is it was expressed, 
fused to a coat protein, on the surface of bacteriophages. The DNA strand carried by these 
phages encodes not only the antibody but also an antibiotic resistance gene. When bacteria 
are infected the phage DNA is transmitted and renders the bacteria resistant to the 
antibiotic. This allows estimation of the number of phages (colony forming units) in a given 
sample by infecting non-resistant bacteria with an aliquot of the phage-containing sample, 
spreading them out on an antibiotic containing agar plate and then counting the colonies 
that have grown after overnight incubation. This unique feature of phage-display allows the 
isolation of an antibody with a given specificity by selection of an antibody library 
constructed from appropriate source material on a given antigen. Non-binding phages are 
washed away while binding phages are retained and then eluted. Eluted phages serve to 
infect bacteria, producing a new batch of phages, which is then subjected to a new round of 
selection further amplifying specific binders. We used this technology to isolate antibody 
D9. In this case the antigen used for selection consisted of NOD antigen-presenting cells 
pulsed with NtfrII. The sequence of the NtfrII peptide recognized by D9 in context of I-Ag7 
was identified by pulsing antigen- presenting cells of NOD mice with short peptides 
covering NtfrII and analyzing if the pulsed cells could be stained with D9. We also 
determined that the complex formed by this peptide in context of I-Ag7 NtfrII could activate 
autoreactive CD4+ T-cells. The complex therefore represented the link connecting Reg 
overexpression with the Reg specific immune attack on islets.  
In order to establish a temporal profile of the I-Ag7 NtfrII peptide complexes we collected 
pancreatic lymph nodes of NOD mice at different ages, prepared single cell suspensions and 
exposed them to the antibody. After washing, bound phages were detached, bacteria were 
infected and a colony count was obtained. As a control we used a mutated version of the 
antibody D9, which had a deletion in its heavy chain and only marginally bound to NOD 
antigen-presenting cells pulsed with NtfrII. The numbers of T-cells in the pancreatic lymph 
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Fig. 4. Temporal profile of I-Ag7 NtfrII peptide complexes (A) and spontaneous T-cell 
responses (B) in the pancreatic lymph nodes of NOD mice during the pathogenesis of 
T1DM. The y-axis in (A) displays the ratio of colony forming units (cfus) obtained with a 
binding antibody (D9) to colony forming units obtained with a mutated, non-binding 
antibody (D9mut); the y-axis in (B) displays the ratio (SI=stimulation index) of the number 
of spots obtained when cells of the pancreatic lymph nodes were incubated with NtfrII to 
the number of spots obtained when cells of the pancreatic lymph nodes were incubated 
without antigen (ELISPOT assay for IL-2). Both profiles show the same biphasic pattern but 
the T-cell pattern is shifted by two weeks i.e. the T-cell response in the pancreatic lymph 
nodes follows the temporal pattern of the I-Ag7 NtfrII peptide complexes.  
nodes that responded to stimulation with NtfrII were also counted. On plotting both curves 
(NtfrII peptide I-Ag7 complexes and number of T-cells reactive for NtfrII) we observed that 
both curves had a biphasic profile and that the ‘T-cell’ curve followed the ‘complex’ curve 
with a delay of about two weeks (Fig. 4 A and B). This biphasic profile observed would 
clearly rule out the continuous operation of a vicious circle but suggests a temporary 
operation between 6 and 10 weeks of age. It also hints at the tight control of Reg expression. 
Reg does appear to become overexpressed in response to islet inflammation as manifested 
by the increase of I-Ag7 NtfrII peptide complexes in the pancreatic lymph nodes. However, 
beyond a certain degree (or duration) of the inflammatory process (at ages >8 weeks Fig. 
4A) this response ceases and the islets appear to actually reduce Reg expression. The 
existence of such control mechanisms can also be inferred from the observation that Reg acts 
as a macrophage chemoattractant. In this case an additional vicious circle may be 
constructed, involving IL-6 released from macrophages, which leads to up-regulation of Reg 
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and more influx of macrophages. However, as demonstrated by the discoverers of the 
chemoattractant properties of Reg, the dose response curves do not level off but the 
attractant effect disappears above a certain Reg concentration. These observations exemplify 
two main levels of control that must be considered for the understanding of Reg action. One 
of the control levels is represented by the limits, which the target system imposes on Reg 
action - chemoattractant effect on macrophages - and the other by the limits, which the 
source system imposes on Reg production or release – I-Ag7 NtfrII peptide complexes in 
pancreatic lymph nodes of NOD mice.  
7. Concluding remarks and future research directions  
The Reg family of proteins has been studied for over 25 years and today all mouse and 
human Reg members have been identified. However to date there is no unifying theory of 
Reg action and therefore the large body of work on the effects of Reg in different 
physiological systems remains a collection of unconnected observations. While it is 
important to accumulate more information on the role of individual Reg members, a 
framework needs to be developed within which this information can be placed and 
correlated. Such a unifying theory should be able to explain the seemingly very different 
effects induced by Reg such as, for example, Schwann or -cell mitogenesis and bactericidal 
effects. Currently no such theory exists but its basic components should involve 
carbohydrate binding based on the fact that the unifying structure of the Reg family is a C-
type lectin fold. It should additionally encompass fibril formation and possibly EXTL3 
binding as well as up-regulation of Reg under a wide range of noxious stimuli (cytokine-
mediated or other). Extracellular matrix remodeling might also play a role. These 
components then need to be placed and understood within the framework of regulatory 
constraints imposed by the systems impacted by Reg as well as by those that generate Reg. 
In this review we have drawn attention to areas of Reg research that introduce and 
exemplify some of these components. Development of a theory of Reg action would require 
a change in experimental approach away from ‘what particular function is conveyed by a 
particular Reg member in a specific system?’ to comparative studies concerned with ‘what is 
common to all Reg members, how do they differ and what is the origin of these differences?’ 
implemented with consideration of the basic components of the theory as outlined above. 
Consequently we argue that a model in which not one particular member but an entire 
subfamily or all Reg members have been knocked out would greatly further the 
development of this unifying theory. Such models might allow the characterization of the 
effects of Reg under normal conditions by eliminating the ‘masking effects’ of the likely 
redundancies that occur within the family. How the genomic organization of the Reg family 
would facilitate generation of these models is mentioned above. We are confident that they 
would also reveal that Reg proteins are necessary for islet (re)generation.  
As far as the properties of Reg as autoantigen are concerned we are in the process of 
performing studies that evaluate if the antibodies specific for the Reg peptide MHC 
complexes generated in our laboratory may be useful as therapeutic agents for the treatment 
or prevention of T1DM. An important aim in the prevention and treatment of T1DM is the 
development of a specific immunotherapy, that is an intervention that targets and 
blocks/eliminates specifically self-reactive T-cells but does not affect T-cells, which are 
necessary for the normal functioning of the immune system. This aim can be achieved by 
intervening with the process that generates specificity in the immune system, namely the 
www.intechopen.com
The Role of Reg Proteins, a Family of Secreted 
C-Type Lectins, in Islet Regeneration and as Autoantigens in Type 1 Diabetes 
 
179 
binding of the T-cell receptor to its antigen, which is the complex formed by the T-cell 
epitope and the presenting MHC. An antibody that recognizes this complex, such as D9 
introduced here, might interfere with the activation of the self-reactive T-cell recognizing the 
same complex and could represent a potential means to achieve specific immune 
suppression. A variant of this approach is the active vaccination with the receptor of a self-
reactive T-cell in order to generate an immune response that targets only T-cells with this 
receptor but not others. This approach is known as anti-idiotypic vaccination and has been 
tested with some success in models of other autoimmune diseases. Which of these 
approaches might actually be practicable and effective in the treatment of T1DM will be the 
focus of future studies in our laboratory.   
A successful therapy for T1DM will likely have two main components; one designed to 
support or enhance islet protection/regeneration and the other to control the aberrant 
immune response. Although more widely studied autoantigens like insulin or glutamic acid 
decarboxylase might be more suitable for addressing the control of the aberrant immune 
response, Reg is unique in that it represents an islet component that can play a role in 
relation to both therapeutic main approaches through its impact on islet regeneration on the 
one hand and its role as autoantigen on the other hand.  
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